Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/4/26 20:12 | 2/3/26 | TNGX | Health | Drug | Pharmaceutical Preparations | Beckman Daniella | MA | O | CFO | 2 | S.dm | -152 | 8.18 | 0 | -19 | 184 | D | |||||||||||||||
2/4/26 20:09 | 2/3/26 | TNGX | Health | Drug | Pharmaceutical Preparations | Weber Barbara | MA | DO | Dir,Exec | 2 | S.dm | -432 | 8.76 | 0 | -49 | 1,629 | D | |||||||||||||||
2/4/26 20:02 | 2/3/26 | TNGX | Health | Drug | Pharmaceutical Preparations | Crystal Adam | MA | O | P,R,D | 2 | S.dm | -270 | 8.25 | 0 | -33 | 187 | D | |||||||||||||||
10/27/25 16:15 | 10/23/25 | TNGX | Health | Drug | Pharmaceutical Preparations | Third Rock Ventures Iv, L.P. | MA | T | 6 | S.m | -26,351 | 7.59 | 0 | -3,473 | 15,759 | D | ||||||||||||||||
2/6/25 20:21 | 2/4/25 | TNGX | Health | Drug | Pharmaceutical Preparations | Barry Douglas | MA | O | GC | 1 | S.m | -16 | 3.07 | 0 | -5 | 66 | D | |||||||||||||||
11/8/24 19:24 | 11/6/24 | TNGX | Health | Drug | Pharmaceutical Preparations | Ecor1 Capital, LLC | CA | T | 1 | S.m | -8,436 | 3.12 | 0 | -2,700 | 10,631 | I | ||||||||||||||||
11/7/24 21:30 | 11/6/24 | TNGX | Health | Drug | Pharmaceutical Preparations | Boxer Capital Management, LLC | CA | H | See rema | 3 | S.m | -20,121 | 4.39 | 0 | -4,588 | 14,421 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |